Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICD Coverage Saga Reaches Dénouement With SCD-HeFT Study Publication

This article was originally published in The Gray Sheet

Executive Summary

CMS says it likely will issue a final ICD coverage decision Jan. 26, with the publication of Medtronic's SCD-HeFT study in the New England Journal of Medicine.

You may also be interested in...



Research In Brief

NIH-funded research yields biomarker test of kidney transplant rejection. Dual-coil leads are not worth the extra effort in primary prevention ICD patients. More research news.

Harvard Physician Questions Latest ICD Cost-Effectiveness Analysis

Only a small percentage of patients with implantable cardioverter defibrillators who receive appropriate shocks actually survive long enough to make the devices cost-effective, states a leading cardiologist

Harvard Physician Questions Latest ICD Cost-Effectiveness Analysis

Only a small percentage of patients with implantable cardioverter defibrillators who receive appropriate shocks actually survive long enough to make the devices cost-effective, states a leading cardiologist

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel